ABSTRACT
We report on a fetal case of Ebstein's anomaly with severe tricuspid regurgitation, functional pulmonary atresia and progressive circular shunting (CS) across a widely patent ductus arteriosus (DA) and regurgitant pulmonary valve, contributing to significant systemic hypoperfusion. To mitigate the extent of CS and allow the pregnancy to continue, maternal non-steroidal anti-inflammatory drug (NSAID) therapy with indomethacin was started at 33 + 5 weeks to induce DA constriction. Rather than achieving the desired narrowing of the DA, the treatment led to its complete closure and only minimal antegrade flow across the pulmonary valve. While closure of the DA resulted in the anticipated improvement in fetal hemodynamics, at birth, the child was at risk of severe hypoxemia and its consequences due to the lack of adequate pulmonary perfusion. Reduction and eventual discontinuation of the NSAID treatment did not result in DA reopening. Our experience illustrates the risk of unintended irreversible DA closure when NSAIDs are used to treat CS. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Ductus Arteriosus, Patent/drug therapy , Ductus Arteriosus/drug effects , Ebstein Anomaly/drug therapy , Indomethacin/administration & dosage , Administration, Oral , Administration, Rectal , Ductus Arteriosus, Patent/embryology , Ebstein Anomaly/embryology , Ebstein Anomaly/pathology , Female , Humans , Maternal-Fetal Exchange , Medical Illustration , Pregnancy , Pulmonary Atresia/drug therapy , Pulmonary Atresia/embryology , Pulmonary Valve Insufficiency/drug therapy , Pulmonary Valve Insufficiency/embryology , Tricuspid Valve Insufficiency/drug therapy , Tricuspid Valve Insufficiency/embryologyABSTRACT
OBJECTIVE: To examine the association between fetal major heart defects and increased nuchal translucency thickness (NT), tricuspid regurgitation and abnormal flow in the ductus venosus in a large population of singleton pregnancies undergoing routine ultrasound examination at 11-13 weeks' gestation. METHODS: This was a retrospective study of prospectively collected data from singleton pregnancies attending for a routine ultrasound scan at 11-13 weeks' gestation, which included examination of fetal anatomy, measurement of NT and assessment of blood flow across the tricuspid valve and in the ductus venosus, according to a standardized protocol. The incidence of fetal NT ≥ 95th and ≥ 99th percentiles, tricuspid regurgitation and reversed a-wave in the ductus venosus in fetuses with and those without a major heart defect was determined and the performance of each marker and their combination in the detection of major heart defects was calculated. RESULTS: The study population of 93 209 pregnancies with no apparent chromosomal abnormality included 211 (0.23%) with a fetal major heart defect and 92 998 morphologically normal neonates. In 113 (53.6%) cases with a major heart defect, the diagnosis was made at the 11-13-week scan, in 82 (38.9%) at the 18-24-week scan, in 10 (4.7%) at the third-trimester scan and in six (2.8%) postnatally. At the 11-13-week scan, we diagnosed all cases of tricuspid or pulmonary atresia and polyvalvular dysplasia, > 90% of cases of hypoplastic left heart syndrome or atrioventricular septal defect, about 60% of complex heart defects and cases of left atrial isomerism (interrupted inferior vena cava with normal intracardiac anatomy), 30-40% of cases of tetralogy of Fallot and arch abnormalities, 25% of tricuspid valve abnormalities and about 15% of cases of transposition of the great arteries, but none of aortic or pulmonary stenosis or common arterial trunk. Fetal NT ≥ 95th or ≥ 99th percentile, tricuspid regurgitation or abnormal ductus venosus flow was observed in 77 (36.5%), 45 (21.3%), 61 (28.9%) and 58 (27.5%) fetuses with a major heart defect, respectively, and in 5678 (6.1%), 857 (0.9%), 1136 (1.2%) and 1644 (1.8%) of those without a heart defect. Any one of NT ≥ 95th percentile, tricuspid regurgitation or abnormal flow in the ductus venosus was found in 117 (55.5%; 95% CI, 48.5-62.3%) fetuses with a heart defect and in 8166 (8.8%; 95% CI, 8.6-9.0%) of those without a heart defect. Any one of NT ≥ 99th percentile or the other two markers was found in 99 (46.9%; 95% CI, 40.0-53.9%) fetuses with a heart defect and in 3517 (3.8%; 95% CI, 3.7-3.9%) of those without a heart defect. CONCLUSION: At 11-13 weeks' gestation, measurement of fetal NT and assessment of flow across the tricuspid valve and in the ductus venosus can lead to early diagnosis of major heart defect. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
Subject(s)
Ductus Arteriosus, Patent/diagnostic imaging , Fetal Heart/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Nuchal Translucency Measurement/statistics & numerical data , Tricuspid Valve Insufficiency/diagnostic imaging , Adult , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/epidemiology , Early Diagnosis , Female , Fetal Heart/embryology , Fetal Heart/physiopathology , Gestational Age , Heart Defects, Congenital/embryology , Heart Defects, Congenital/epidemiology , Humans , Incidence , Infant, Newborn , Nuchal Translucency Measurement/methods , Predictive Value of Tests , Pregnancy , Pregnancy Trimester, First , Prospective Studies , Pulsatile Flow , Retrospective Studies , Transposition of Great Vessels/diagnostic imaging , Transposition of Great Vessels/embryology , Transposition of Great Vessels/epidemiology , Tricuspid Valve Insufficiency/embryology , Tricuspid Valve Insufficiency/epidemiologyABSTRACT
OBJECTIVE: Risk of fetotoxicity after paracetamol exposure in the third trimester. DESIGN: Observational cohort study and retrospective case assessment. SETTING: Germany, 2008-2017. POPULATION: Pregnant women exposed to paracetamol. METHODS: Prospectively enrolled third-trimester pregnancies that had been exposed to paracetamol (604) were compared with pregnancies exposed to paracetamol in the first and/or second trimester only (1192). Exclusion criteria were exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) in the second or third trimester. Additionally, the Embryotox 'adverse drug reaction in pregnancy' database was screened for cases of fetotoxicity. MAIN OUTCOME MEASURES: The prenatal study end points focused on narrowing or closure of ductus arteriosus Botalli, late fetal death, and oligohydramnios. The postnatal end points included patent ductus arteriosus (PDA), primary pulmonary hypertension (PPHT), and impaired renal function. RESULTS: In both cohorts, no fetus with intrauterine narrowing or closure of the ductus arteriosus Botalli was reported (0/604 versus 0/1192). Oligohydramnios was diagnosed at a similar frequency in both cohorts: 1.3% (8/604) versus 1.6% (19/1192). There was one stillbirth in the study cohort (1/604, 0.2%) and four stillbirths in the comparison cohort (4/1192, 0.3%). The rates of PDA in neonates were similar: 0.7% (4/615) versus 0.7% (9/1212). PPHT as well as serious postnatal renal disorders were reported once in each cohort. In 12 out of 96 retrospective cases, there were indicators for study end points; however, co-exposure to NSAIDs or complex situations weaken the assumption of paracetamol toxicity. CONCLUSIONS: Fetal cardiovascular or renal toxicity of maternal third-trimester paracetamol use appears to be negligible. TWEETABLE ABSTRACT: Paracetamol use in the third trimester does not seem to be associated with a relevant risk of fetotoxicity.
Subject(s)
Acetaminophen/administration & dosage , Analgesics, Non-Narcotic/administration & dosage , Ductus Arteriosus, Patent/chemically induced , Kidney Diseases/chemically induced , Kidney/drug effects , Acetaminophen/adverse effects , Adult , Analgesics, Non-Narcotic/adverse effects , Ductus Arteriosus, Patent/embryology , Female , Humans , Infant, Newborn , Kidney/abnormalities , Kidney/embryology , Kidney Diseases/embryology , Pregnancy , Pregnancy Trimester, Third , Retrospective Studies , Risk AssessmentABSTRACT
Tetralogy of Fallot/Absent Pulmonary Valve (TOF/APV) has been classically associated with the absence of a patent ductus arteriosus (PDA). We present a rare case of APV in TOF with a discontinuous left pulmonary artery (LPA) that was suspected during fetal echocardiogram. Postnatal echocardiogram confirmed the origin of a hypoplastic LPA from the PDA. Despite an aneurysmal (right pulmonary artery) (RPA), axial imaging demonstrated widely patent tracheobronchial system with no evidence of bronchial compression. Clinically, the child required only minimal respiratory support. Genetic testing was positive for 22 q11deletion, commonly associated with this lesion. Surgery consisted of unifocalization of the discontinuous LPA with placement of a valved pulmonary homograft during complete repair of this lesion. Our case highlights the importance of prenatal detection, to aid in the prompt initiation of prostaglandins so as to ensure early rehabilitation of the left lung. Inability to visualize one of the branch pulmonary arteries (PA's) and a PDA on fetal echocardiogram in TOF/APV must raise suspicion for an eccentric branch PA with ductal origin.
Subject(s)
Ductus Arteriosus, Patent/complications , Echocardiography/methods , Pulmonary Artery/abnormalities , Pulmonary Valve/abnormalities , Tetralogy of Fallot/complications , Ultrasonography, Prenatal/methods , Adult , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/embryology , Female , Humans , Infant, Newborn , Pregnancy , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/embryology , Pulmonary Valve/diagnostic imaging , Pulmonary Valve/embryology , Tetralogy of Fallot/diagnostic imaging , Tetralogy of Fallot/embryology , Young AdultABSTRACT
BACKGROUND: Patent ductus arteriosus (PDA) is common in premature infants. Cyclooxygenase inhibitors such as indomethacin, which inhibit prostaglandin E2(PGE2) synthesis, are currently the sole treatments for patients with PDA. Their efficacy are, however, frequently limited, and adverse effects are problematic. Because the PGE2-specific receptor EP4 selectively expresses in rat ductus arteriosus (DA), it is hypothesized that EP4 inhibition would promote DA closure with fewer side-effects.MethodsâandâResults:A new chemical compound EP4 antagonist, RQ-15986 (renamed from CJ-042794), was used. Whether RQ-15986 selectively contracted the DA was examined by measuring the isometric tension of rat DA ex vivo at embryonic day 19 (e19) and e21. RQ-15986 at a dose of 10-6mol/L increased the isometric tension of the DA up to 44.8±6.2% and 69.1±12.9% to the maximal KCl-induced tension at e19 and e21 respectively. The effect of RQ-15986 on rat DA in vivo was also tested by using a rapid whole-body freezing method. RQ-15986 inhibited PGE1-induced DA dilatation in neonatal rats. Furthermore, RQ-15986 contracted the DA in a dose-dependent manner, and the constriction was greater at e21 than at e19. Moreover, RQ-15986 did not contract the aorta or the marginal artery of the colon. CONCLUSIONS: EP4 inhibition contracts rat DA with fewer side-effects. EP4 inhibition is a promising alternative strategy to treat patients with PDA.
Subject(s)
Benzamides/pharmacology , Ductus Arteriosus/embryology , Myocardial Contraction/drug effects , Receptors, Prostaglandin E, EP4 Subtype/antagonists & inhibitors , Animals , Dinoprostone/metabolism , Ductus Arteriosus/pathology , Ductus Arteriosus, Patent/embryology , Rats , Rats, WistarABSTRACT
OBJECTIVE: Foetal ductal problems may have various cardiopulmonary consequences. This study aimed to identify the spectrum of ductus arteriosus (DA) dysfunction (closure, constriction, kinking, aneurysm and thrombosis) and the resultant clinical and echocardiographic presentation in foetuses and neonates. METHODS AND RESULTS: This is a retrospective analysis of serial pre- and post-natal data of 27 cases of foetal ductal dysfunction diagnosed at a median gestational age of 33 weeks (range 20-39). The most common abnormalities observed were premature closure of the DA in 56% (15/27) and constriction in 29% (8/27). Right ventricular hypertrophy was present in 75% (n = 11/15) of foetuses with premature DA closure, while ventricular dilation (4/7, 57%) was a more common feature in foetuses with ductal constriction. After birth, 63% (17/27) of new borns presented with cyanosis and pulmonary hypertension that required active treatment. Three infants died after birth. Abnormalities resolved spontaneously after birth in about 50% of patients. In some children, pulmonary valve stenosis and regurgitation was progressive and required further treatment. CONCLUSIONS: An abnormal right heart on foetal four-chamber ultrasound view should alert the sonographer to the possible presence of foetal ductal dysfunction. Ductal occlusion, transient or fixed constriction, kinking and aneurysm formation are associated with foetal cardiopulmonary sequelae. Symptoms and pathology is probably related to the type, foetal age, rapidity of progression and duration of intrauterine ductal dysfunction. Correspondingly, clinical outcomes vary ranging from little or no symptoms to severe respiratory distress and even foetal or neonatal death.
Subject(s)
Ductus Arteriosus, Patent/physiopathology , Ductus Arteriosus/diagnostic imaging , Ventricular Function, Right/physiology , Ductus Arteriosus/embryology , Ductus Arteriosus, Patent/diagnosis , Ductus Arteriosus, Patent/embryology , Echocardiography , Female , Follow-Up Studies , Gestational Age , Heart Ventricles/diagnostic imaging , Heart Ventricles/embryology , Heart Ventricles/physiopathology , Humans , Infant, Newborn , Pregnancy , Retrospective Studies , Ultrasonography, PrenatalABSTRACT
In general, solitary right aortic arch carries the left-sided ductus arteriosus communicating between the left subclavian and pulmonary arteries or the right-sided ductus connecting the descending aorta to the left pulmonary artery. Serial sections of fifteen 5- to 6-week-old embryos and ten 8- to 9-week-old fetuses suggested that the pathogenesis was unrelated to inversion due to dysfunction in gene cascades that control the systemic left/right axis. With inversion, conversely, the ductus or the sixth pharyngeal arch artery should connect to the right pulmonary artery. The disappearance of the right aortic arch started before the caudal migration of the aortic attachment of the ductus. Sympathetic nerve ganglia developed immediately posterior to both aortae, with a single embryonic specimen showing a large ganglion at the midline close to the union of the aortic arches. These ganglia may interfere with blood flow through the distal left arch, resulting in the ductus ending at the descending aorta behind the oesophagus. In another fetus examined, a midline shift of the ductus course resulted in the trachea curving posteriorly. Therefore, solitary right arch is likely to accompany abnormalities of the surrounding structures. The timing and site of the obstruction should be different between types: an almost midline obstruction near the aortic union needed for the development of the left-sided ductus and a distal obstruction near the left subclavian arterial origin needed for the development of the right-sided ductus. A mass effect of the sympathetic ganglia may explain the pathogenesis of any type of anomalous ductus arteriosus shown in previous reports of the solitary right arch.
Subject(s)
Aorta, Thoracic/abnormalities , Ductus Arteriosus, Patent/diagnosis , Fetus , Vascular Malformations/embryology , Aorta, Thoracic/embryology , Ductus Arteriosus/embryology , Ductus Arteriosus, Patent/embryology , HumansSubject(s)
Aorta, Thoracic/diagnostic imaging , Ductus Arteriosus, Patent/diagnostic imaging , Echocardiography , Subclavian Artery/diagnostic imaging , Ultrasonography, Prenatal , Adult , Aorta, Thoracic/embryology , Ductus Arteriosus, Patent/embryology , Female , Humans , Medical Illustration , Pregnancy , Subclavian Artery/embryologySubject(s)
Ductus Arteriosus, Patent/diagnostic imaging , Pulmonary Artery/abnormalities , Pulmonary Artery/diagnostic imaging , Ultrasonography, Prenatal/methods , Adult , Ductus Arteriosus/diagnostic imaging , Ductus Arteriosus/embryology , Ductus Arteriosus, Patent/embryology , Female , Humans , Pregnancy , Pulmonary Artery/embryologySubject(s)
Abnormalities, Multiple/diagnosis , Aorta, Thoracic/abnormalities , Double Outlet Right Ventricle/diagnosis , Ductus Arteriosus, Patent/diagnosis , Abnormalities, Multiple/embryology , Aorta, Thoracic/embryology , Double Outlet Right Ventricle/embryology , Ductus Arteriosus, Patent/embryology , Female , Humans , InfantABSTRACT
Closure of the ductus arteriosus requires prenatal formation of intimal cushions, which occlude the vessel lumen at birth. Survival of newborns with severe congenital heart defects, however, depends on ductal patency. We used a gene transfer approach to create a patent ductus arteriosus by targeting the fibronectin-dependent smooth muscle cell migration required for intimal cushion formation. Fetal lamb ductus arteriosus was transfected in utero with hemagglutinating virus of Japan liposomes containing plasmid encoding 'decoy' RNA to sequester the fibronectin mRNA binding protein. Fibronectin translation was inhibited and intimal cushion formation was prevented. We thus established the essential role of fibronectin-dependent smooth muscle cell migration in intimal cushion formation in the intact animal and the feasibility of incorporating biological engineering in the management of congenital heart disease.
Subject(s)
Ductus Arteriosus, Patent/genetics , Fibronectins/genetics , Fibronectins/physiology , Genetic Therapy/methods , Transfection/methods , Animals , Cell Movement/genetics , Disease Models, Animal , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/surgery , Female , Genetic Vectors , Heart Defects, Congenital/mortality , Heart Defects, Congenital/pathology , Heart Defects, Congenital/therapy , Liposomes , Muscle, Smooth, Vascular/cytology , Plasmids , Pregnancy , Protein Biosynthesis , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Respirovirus , SheepABSTRACT
Tetralogy of Fallot with absent pulmonary valve syndrome is a rare form of congenital heart disease. Among the different variations with this rare anomaly is nonconfluent pulmonary artery branches with anomalous origin of the left pulmonary artery from the ductus arteriosus. The authors present one such case which was diagnosed prenatally to have tetralogy of Fallot with absent pulmonary valve and identified postnatally to have nonconfluent pulmonary artery branches in addition. We discuss the conundrum of respiratory management in this patient pre- and postoperatively due to a unique ventilation perfusion mismatch problem, which varies between the two lungs.
Subject(s)
Ductus Arteriosus, Patent/diagnosis , Echocardiography/methods , Prenatal Diagnosis , Pulmonary Artery/abnormalities , Pulmonary Atresia/diagnosis , Pulmonary Valve/abnormalities , Tetralogy of Fallot/diagnosis , Ductus Arteriosus, Patent/embryology , Fatal Outcome , Female , Humans , Infant, Newborn , Male , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/embryology , Pulmonary Atresia/embryology , Pulmonary Valve/diagnostic imaging , Pulmonary Valve/embryology , Tetralogy of Fallot/embryology , Tomography, X-Ray Computed , Young AdultABSTRACT
The ductus arteriosus (DA) has been studied since Galen. Initially after birth in neonates with obstruction to pulmonary blood flow, DA patency is integral to ensure output and oxygenation. While DA stenting dates back 25 years, there is emerging interest in better understanding how and when to utilize this strategy as an alternative to surgical shunt placement or ongoing prostaglandin administration. Understanding the normal fetal circulation and the perturbations that affect flow and oxygenation is integral to comprehending how normal DA anatomy and morphology may change and how this may influence technical and clinical considerations. In the normal human fetus the great majority of descending aorta circulation comes from the DA, whereas this is a small minority in pulmonary outflow lesions, resulting in size and angle abnormalities. Study of the DA morphology has previously sought to identify patients requiring early intervention and more novel classifications are contributing to knowledge of complications and increasing the likelihood of success. As well, optimal patient selection for aorto-pulmonary shunt vs DA stent remains unclear. This review seeks to convey how fetal circulation can affect the DA, how other clinical considerations such as neurocognitive development support these finding and influence management, and emphasize that the variability in the DA will affect suitability for stenting, which requires further study as guidelines and standards are developed.
Subject(s)
Ductus Arteriosus, Patent/embryology , Ductus Arteriosus/embryology , Fetus/blood supply , Pulmonary Circulation/physiology , Regional Blood Flow/physiology , Ductus Arteriosus/physiopathology , Ductus Arteriosus, Patent/physiopathology , Female , Hemodynamics/physiology , Humans , Infant, Newborn , PregnancySubject(s)
Ductus Arteriosus, Patent/genetics , Fibronectins/genetics , Fibronectins/physiology , Genetic Therapy/methods , Transfection/methods , Animals , Cell Movement , Disease Models, Animal , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/surgery , Female , Heart Defects, Congenital/mortality , Heart Defects, Congenital/pathology , Heart Defects, Congenital/therapy , Muscle, Smooth, Vascular/cytology , Pregnancy , SheepABSTRACT
Septation defects and patent ductus arteriosus are the most common human cardiovascular malformations (CVMs). Genetic factors play a major part in the origin of these malformations. Recent molecular analyses have shed light on several mendelian forms. In the autosomal dominant Holt-Oram syndrome, both atrial and ventricular septal defects are inherited in association with limb deformity as a result of mutations in the gene encoding the TBX5 transcription factor. Mutations in the NKX2.5 transcription factor gene cause autosomal dominant familial atrial septal defects in association with progressive atrioventricular block as well as complex congenital heart disease. Common atrial syndromes in autosomal dominant Ellis-van Creveld syndrome arise in the context of axial skeletal and limb malformation as a result of mutations in the EVC gene, whose function is unknown. Patent ductus arteriosus occurs in several syndromic forms of congenital heart disease, including Holt-Oram syndrome. Recent analyses of autosomal dominant Char syndrome, which includes, with variable penetrance, patent ductus arteriosus as well as craniofacial and hand malformations, have shown that the syndrome is caused by mutations in the TFAP2B transcription factor gene. Ongoing analyses are poised to determine the contribution of these genes as well as others yet to be identified to common, sporadic forms of congenital heart disease.
Subject(s)
Ductus Arteriosus, Patent/genetics , Heart Septal Defects, Atrial/genetics , Heart Septal Defects, Ventricular/genetics , Xenopus Proteins , Abnormalities, Multiple/genetics , Abnormalities, Multiple/pathology , Animals , Cell Movement , Chick Embryo , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Down Syndrome/pathology , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/epidemiology , Ellis-Van Creveld Syndrome/genetics , Ellis-Van Creveld Syndrome/pathology , Endocardial Cushion Defects/embryology , Endocardial Cushion Defects/genetics , Female , Fetal Heart/pathology , Gene Expression Regulation, Developmental , Genes, Dominant , Genetic Linkage , Heart Septal Defects, Atrial/embryology , Heart Septal Defects, Ventricular/embryology , Homeobox Protein Nkx-2.5 , Homeodomain Proteins/genetics , Homeodomain Proteins/physiology , Humans , Male , Membrane Proteins , Mice , Models, Animal , Neural Crest/cytology , Pedigree , Proteins/genetics , Proteins/physiology , Syndrome , T-Box Domain Proteins/deficiency , T-Box Domain Proteins/genetics , T-Box Domain Proteins/physiology , Transcription Factor AP-2 , Transcription Factors/deficiency , Transcription Factors/genetics , Transcription Factors/physiologyABSTRACT
Findings from the autopsy of a preterm neonate with in utero anatomic closure of the ductus arteriosus in association with prune belly syndrome are presented. Marked bladder distention, a major feature of prune belly syndrome, has secondary mechanical effects on fetal thoracic organs, and the fetus might have been exposed to chronic intrauterine stress. This could have affected the prenatal closure of the ductus arteriosus, although no definitive conclusion can be made.
Subject(s)
Ductus Arteriosus, Patent/complications , Prune Belly Syndrome/complications , Ductus Arteriosus/pathology , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/pathology , Humans , Infant, Newborn , Male , Prune Belly Syndrome/pathology , Urinary Bladder/pathologyABSTRACT
Bilateral ductus arteriosus (BDA) usually is associated with complex cyanotic heart disease. Since pulmonary valve atresia often is part of the complex, hypoxia may necessitate emergency cardiac catheterization and surgery for these critically ill newborn infants. Optimum management depends on accurate delineation of the intracardiac and great vessel anatomy. Since the ductus arteriosus has a tendency to close spontaneously, the true anatomy of the fourth to sixth aortic arch connections should be determined on the first catheterization. An over-all plan for future care by the medical-surgical team should have been made at the time of the initial surgical procedure. The case histories of four newborn infants with BDA associated with cyanotic heart diseases are reported. The anatomy and basic embryology of the fourth to sixth arch system is reviewed and recommendations for long-term management are given.
Subject(s)
Ductus Arteriosus, Patent/surgery , Aorta, Thoracic/embryology , Cardiac Catheterization , Cineangiography , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/pathology , Female , Humans , Infant, Newborn , MaleABSTRACT
The following conditions were surgically created in fetal lambs at the gestational ages of 80 to 90 days: (1) preductal coarctation, (2) postductal coarctation, (3) pulmonic stenosis, and (4) constriction of the ductus arteriosus. Studies performed at the time of delivery showed the following: Preductal coarctation and postductal coarctation often are associated with a dilated ductus arteriosus that remains patent. Pulmonic stenosis often results in prestenotic and poststenotic dilatation that may include the ductus arteriosus. The fetal ventricles become hypertrophied in response to the increased pressure work imposed by the distal stenoses.
Subject(s)
Aortic Coarctation/embryology , Ductus Arteriosus, Patent/embryology , Pulmonary Valve Stenosis/embryology , Animals , Aortic Coarctation/pathology , Aortic Coarctation/physiopathology , Blood Pressure , Cardiac Output , Cardiomegaly/etiology , Dilatation, Pathologic , Disease Models, Animal , Ductus Arteriosus/pathology , Ductus Arteriosus, Patent/pathology , Female , Pregnancy , Pulmonary Artery/embryology , Pulmonary Artery/pathology , Pulmonary Circulation , SheepABSTRACT
OBJECTIVE: To review current data pertaining to prenatal ultrasonography of the ductus arteriosus. DATA SOURCES: We reviewed manuscripts published in the English language regarding prenatal ultrasonography and the fetal ductus arteriosus obtained from a MEDLINE search for 1966 onward. Additional sources were identified through cross-referencing. METHODS OF STUDY SELECTION: Data regarding morphology, physiology, pathophysiology of fetal disease, and hemodynamic changes after administration of various maternal medications and structural congenital anomalies of the ductus arteriosus were selected. DATA EXTRACTION AND SYNTHESIS: Knowledge of the function of the ductus arteriosus in both normal and abnormal fetal conditions is enhanced by prenatal ultrasonographic findings. Detailed analyses of ductus arteriosus hemodynamics are indicated in well-defined medical conditions, including maternal medication and established structural or functional fetal cardiac disease. CONCLUSION: The fetal ductus arteriosus is a vascular structure of major functional importance. Knowledge of physiologic hemodynamic changes of blood flow in this vessel obtained by prenatal ultrasonography in conjunction with increasing gestational age, maternal medication, fetal growth restriction, as well as the detection of structural anomalies, may assist in clinical management of complicated pregnancies.
Subject(s)
Ductus Arteriosus/diagnostic imaging , Ductus Arteriosus/embryology , Ultrasonography, Prenatal , Ductus Arteriosus, Patent/diagnostic imaging , Ductus Arteriosus, Patent/embryology , Ductus Arteriosus, Patent/etiology , Female , Humans , PregnancyABSTRACT
Three cases of severe costovertebral deformities together with embryologically related cardiac malformations (Fallots Tetralogy and Truncus arteriosus communis) are presented. Two patients died because of their thoracic deformities and limited respiratory function. Relationships to similar bizarre veretebral anomalies are discussed. The cause is probably a teratogenic agent, acting between the fifth to eight embryologic week.